Alembic Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,430
1,340
1,275
1,403
1,252
Cost of Goods Sold (COGS) incl. D&A
1,240
1,335
1,171
1,293
1,098
Gross Income
189
4
105
110
155
SG&A Expense
51
65
84
70
59
EBIT
100
51
-
-
74
Unusual Expense
79
1
32
62
49
Non Operating Income/Expense
179
279
279
301
316
Interest Expense
40
8
-
-
-
Pretax Income
335
235
253
266
442
Income Tax
39
7
6
9
24
Equity in Affiliates
-
-
2,098
1,179
1,212
Consolidated Net Income
295
241
2,345
1,454
1,630
Net Income
295
241
2,345
1,454
1,630
Net Income After Extraordinaries
295
241
2,345
1,454
1,630
Net Income Available to Common
295
241
2,345
1,454
1,630
EPS (Basic)
1.11
0.90
8.78
5.44
6.10
Basic Shares Outstanding
267
267
267
267
267
EPS (Diluted)
1.11
0.90
8.78
5.44
6.10
Diluted Shares Outstanding
267
267
267
267
267
EBITDA
180
10
64
69
112
Other Operating Expense
38
10
18
21
22
Non-Operating Interest Income
17
14
3
9
2

About Alembic

View Profile
Address
Alembic Road
Vadodara Gujarat 390003
India
Employees -
Website http://www.alembiclimited.com
Updated 09/14/2018
Alembic Ltd. is a pharmaceutical holding company. It operates through the Active Pharmaceutical Ingredient (API) and Real Estate business segments. The API segment manufactures and markets fermentation and chemistry based API.